Placement Announced

Werewolf Therapeutics placement

US$150m raised

Announced 21 Aug 2026 · NASDAQ: HOWL

Advisers

Werewolf Therapeutics

Issuer

Not disclosed

Issuer
Werewolf Therapeutics
Issuer based in
United States
Sector
Biotech
Tags
Biotech, Drug Development, Rare Disease

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.